Cue Health Inc. (HLTH) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...

SAN DIEGO, Calif.--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its second quarter 2023 financial results on Wednesday ...

Good day and thank you for standing by and welcome to the Cue Health First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced strategic actions implemented by its Board of Directors (the ...

Cue Health Inc (NASDAQ:HLTH) became the first company to receive De Novo authorization from the FDA for its Cue COVID-19 Molecular Test, designed for both home and point-of-care use. The de novo is a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Board Appoints Two Strategic Advisors Who Bring Significant Industry Expertise SAN DIEGO--(BUSINESS WIRE)-- Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, ...

Cue Health Inc. misses on earnings expectations. Reported EPS is $-0.62 EPS, expectations were $-0.61. Operator: Good day and thank you for standing by and welcome to the Cue Health First Quarter 2023 ...

Cue Health Inc. (NASDAQ: HLTH) Q4 2022 Earnings Call Transcript March 15, 2023 Operator: Good day, and thank you for standing by. Welcome to the Cue Health Fourth Quarter 2022 Earnings Conference Call ...

Cue Health Inc. (HLTH) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...